In 6 months time we should see some good traction with SequestOx & bring in solid revs to support other trials. In addition, we file 2 more NDA's by year end + time for FDA to accept brings us out about 8 months + a little flexibility - around March. Just my estimate, but all based on approval in March.
Nasrat said he'd uplist naturally by end of year. If we don't (naturally)he will reverse split to get us there. . He also said he won't do it until we are fundamentally and 100% stable for the RS. Tis was on one of the last couple conference calls.
Market Data 
Markets 
AI
